Dr. Heidi Waldorf, MD – Nanuet, NY
James Williams technology trends
Pilot, multicenter, open-label evaluation of safety, tolerability and efficacy of a novel, topical multipotent growth factor formulation for the periorbital region
Sundaram H, Gold M, Waldorf HA, Lupo M, Nguyen V, Karnik J, J of Drugs in Dermatol, 1/1/2015Abbreviations for device names: a proposed methodology with specific examples
Alam M, Dover JS; American Society for Dermatologic Surgery Lexicon Task Force; Subsection chairs: Alam M, Goldman MP, Kaminer MS, Orringer J, Waldorf HA, Alam M, Avra..., Dermatol Surg, 1/1/2013A review of AbobotulinumtoxinA (Dysport)
Lorenc ZP, Kenkel JM, Fagien S, Hirmand H, Nestor MS, Sclafani AP, Sykes JM, Waldorf HA, Aesthet Surg J, 1/1/2013
